HIGHLIGHTS
- who: Vladimir Adrien from the Stanford University, United States have published the article: Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid, in the Journal: (JOURNAL) of December/22,/2021
- what: The aim of this paper is to examine to what extent blood biomarkers coupled with clinical and cognitive data can contribute to disentangle disease heterogeneity and improve treatment in clinically stabilized schizophrenic patients. In this manuscript, the authors focused on two polyunsaturated_fatty_acid (PUFA) families with distinct properties. It could also pave the way for future . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.